Theranostics of Neuroendocrine Tumors.

about

Theranostics of Neuroendocrine Tumors.

Item

http://www.wikidata.org/entity/Q49612068

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Theranostics of Neuroendocrine Tumors.

@en

Theranostics of Neuroendocrine Tumors.

@nl

type

Item

label

Theranostics of Neuroendocrine Tumors.

@en

Theranostics of Neuroendocrine Tumors.

@nl

prefLabel

Theranostics of Neuroendocrine Tumors.

@en

Theranostics of Neuroendocrine Tumors.

@nl

P1476

Theranostics of Neuroendocrine Tumors.

@en

P2093

Aviral Singh

http://www.w3.org/2001/XMLSchema#string

Harshad R Kulkarni

http://www.w3.org/2001/XMLSchema#string

Richard P Baum

http://www.w3.org/2001/XMLSchema#string

Sze Ting Lee

http://www.w3.org/2001/XMLSchema#string

P2860

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.

Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours

Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours.

Hematological toxicity of combined 177Lu-octreotate radiopeptide chemotherapy of gastroenteropancreatic neuroendocrine tumors in long-term follow-up.

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

Molecular imaging with ⁶⁸Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours.

90Y-edotreotide for metastatic carcinoid refractory to octreotide.

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.

P304

358-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000480383

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29177165

http://www.w3.org/2001/XMLSchema#string

P932

5697502

http://www.w3.org/2001/XMLSchema#string